Flamel Technologies
Flamel Technologies is a pharmaceutical company engaged in developing therapeutics of polymer based technology. The company's technology platform contains advanced biological and chemical drugs pipeline.[1] Its headquarter is now in Vénissieux, France. [2] The company is a publicly traded company on NASDAQ under the symbol "FLML". Recent years, the company established joint development agreements with major international pharmaceutical companies such as GlaxoSmithKline, and Merck Serono, Digna Biotech, S.L., and Theralpha, SAS.[3]
| Public | |
| Traded as | NASDAQ:FLML |
| ISIN | 🆔 |
| Industry | Biotechnology |
| Founded 📆 | 1990[4] |
| Founder 👔 | |
| Headquarters 🏙️ | Vénissieux, France |
Area served 🗺️ | |
| Products 📟 | Drugs |
| Members | |
Number of employees | |
| 🌐 Website | www |
| 📇 Address | |
| 📞 telephone | |
History[edit]
Flamel Technologies started its earliest business in 1990. Now, the focus of the company is mainly on development and production of liquid formulated drugs and drugs of abuse-deterrent formulations. [5]
Production[edit]
The main product of Flamel Technologies include Micropump-based microparticles and drugs with Micropump-based technology[6] such as Coreg CR, which is used to moderate heart failure.[7] The company is also in a Phase II clinical trials of its Medusa technology[8] for treating Hepatitis C. [9] In June 2013, the company was approved by the FDA of applying a new drug of Bloxiverz, i.e. neostigmine methylsulfate, which is used during operations for the reversal of non-depolarizing neuromuscular blocking agents effects that happen after surgery. This is a first version of Neostigmine approved by the FDA, after many previous versions unapproved in the market.[10]
References[edit]
- ↑ "History". Retrieved Dec 20, 2013.
- ↑ "profile". Retrieved DEC 23, 2013. Check date values in:
|accessdate=(help) - ↑ "Theralpha announces collaboration and business agreement with Flamel Technologies" (Press release). Retrieved DEC 26, 2013. Check date values in:
|accessdate=(help) - ↑ "Business Summary". Retrieved Dec 22, 2013.
- ↑ "History". Retrieved Dec 20, 2013.
- ↑ Bartiroma, Mario (28 August 2003). "Flamel Technologies - CFO - Interview". CNBC – via HighBeam Research (subscription required). Retrieved 27 December 2013.
- ↑ "New Product Newswire". Drug Topics – via Questia (subscription required). 28 August 2003. Retrieved 11 December 2006.
- ↑ Lene Jorgensen, Hanne Morck Nielson, ed. (2009). Delivery Technologies for Biopharmaceuticals. Wiley. pp. 197–8. Search this book on
- ↑ "Business Summary". Retrieved Dec 25, 2013.
- ↑ "Bloxiverz". Retrieved Dec 25, 2013.
This article "Flamel Technologies" is from Wikipedia. The list of its authors can be seen in its historical. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.
